•
AL
ALKS
Alkermes Inc. plc
polygonPHARMACEUTICAL PREPARATIONS
--
Price Chart
Market Cap
5.59B
Volume
162.50K
52W High
$36.45
52W Low
$25.17
Open
$33.85
Prev Close
$33.85
Day Range
33.51 - 34.37
About Alkermes Inc. plc
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.
Latest News
Avadel Pharmaceuticals Announces that Avadel Shareholders Approve the Proposed Acquisition by Alkermes
Benzinga•Jan 12
Announcement relating to despatch of Definitive Proxy Statement and details of Scheme Meeting and Extraordinary General Meeting
Benzinga•Dec 3
Deal Dispatch: From Four Roses Bourbon To Quantum Stakes, Here Are This Week's Sector Shake Ups
Benzinga•Oct 24
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Avadel Pharmaceuticals plc (NASDAQ: AVDL)
Benzinga•Oct 22
Alkermes Strikes $2.1 Billion Avadel Deal, Gains Access To Narcolepsy Drug Lumryz
Benzinga•Oct 22
6 Analysts Assess Alkermes: What You Need To Know - Benzinga
Benzinga•Jul 15
Orchestra BioMed Holdings, Inc. (OBIO) Stock Jumps 7.3%: Will It Continue to Soar?
Zacks Investment Research•Jun 24
Why Is Alkermes (ALKS) Down 2.7% Since Last Earnings Report?
Zacks Investment Research•May 31